Literature DB >> 20075315

The California stem cell initiative: persuasion, politics, and public science.

Joel W Adelson1, Joanna K Weinberg.   

Abstract

The California Institute for Regenerative Medicine (CIRM) was created by a California ballot initiative to make stem cell research a constitutional right, in response to Bush administration restrictions on stem cell research. The initiative created a taxpayer-funded, multibillion-dollar institution, intended to advance public health by developing cures and treatments for diabetes, cancer, paralysis, and other conditions. The initiative has been highly controversial among stakeholders and watchdog groups concerned with organizational transparency, accountability, and the ethics of stem cell research. We interviewed major stakeholders-both supporters and opponents-and analyzed documents and meeting notes. We found that the CIRM has overcome start-up challenges, been selectively influenced by criticism, and adhered to its core mission.

Entities:  

Mesh:

Year:  2010        PMID: 20075315      PMCID: PMC2820047          DOI: 10.2105/AJPH.2009.168120

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  3 in total

1.  Cryopreserved embryos in the United States and their availability for research.

Authors:  David I Hoffman; Gail L Zellman; C Christine Fair; Jacob F Mayer; Joyce G Zeitz; William E Gibbons; Thomas G Turner
Journal:  Fertil Steril       Date:  2003-05       Impact factor: 7.329

2.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

3.  Virus-free induction of pluripotency and subsequent excision of reprogramming factors.

Authors:  Keisuke Kaji; Katherine Norrby; Agnieszka Paca; Maria Mileikovsky; Paria Mohseni; Knut Woltjen
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

  3 in total
  2 in total

1.  Stem cells: The impatient advocate.

Authors:  Elie Dolgin
Journal:  Nature       Date:  2010-12-02       Impact factor: 49.962

2.  Stem cell research funding policies and dynamic innovation: a survey of open access and commercialization requirements.

Authors:  Maroussia Lévesque; Jihyun Rosel Kim; Rosario Isasi; Bartha Maria Knoppers; Aurora Plomer; Yann Joly
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.